Nancy E. Isaac

Aerogen, Inc. develops and manufactures aerosol products for treatment of respiratory disorders in the critical care setting. Its products include Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-C controller, and USB controller. The company is headquartered in Deerfield, IL.

Broncus Technologies is a medical technology company focused on developing and commercializing innovative solutions for lung diseases. With LungPoint™, physicians plan bronchoscopic procedures and navigate to locations in the lungs accurately and quickly. Its line of Yield™ catheters are used to obtain tissue samples and detect blood vessels. Its patented treatment method, Airway Bypass using Exhale® Drug-Eluting Stents, is being investigated to determine if it can provide the first minimally-invasive treatment option for homogeneous, or diffuse, emphysema, the form of the disease experienced by the majority of emphysema patients.

BD Biosciences, Systems & Reagents, Inc. provides tools and solutions to research and clinical laboratories in basic research, drug discovery, development, biopharmaceutical production and disease management. The company was founded on May 9, 1991 and is headquartered in San Jose, CA.

NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA.

The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015.

Neuraltus Pharmaceuticals, Inc. develops and commercializes molecule therapeutics. It engages in the development of therapeutics to treat neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Parkinson's disease, and Alzheimer's disease as well as inherited metaboloic disorders such as Fabry's disease and Gaucher's disease which also result in neuronal cell death. The company was founded by Michael McGrath, Edgar G. Engleman, and Ari Azhir in 2004 and is headquartered in San Bruno, CA.

Part of Becton, Dickinson & Co., Becton Dickinson Immunocytometry Systems manufactures medical instruments. The company is based in San Jose, CA.

Longwell & Associates is a law firm. The private company is based in Palo Alto, CA.

CardioKinetix, Inc. develops ventricular partitioning device for heart failure disease. It develops transcatheter implant called the Parachute Ventricular Partitioning Device, which intends to treat heart failure resulting from a heart attack in patients by improving overall cardiac function. The company was founded by Alexander Khairkhahan, Serjan D. Nikolic and Hugh R. Sharkey in 2002 and is headquartered in Menlo Park, CA.